We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$23.2B
AUM Growth
+$1.67B
Cap. Flow
+$913M
Cap. Flow %
3.93%
Top 10 Hldgs %
55.65%
Holding
2,074
New
189
Increased
821
Reduced
706
Closed
172

Sector Composition

Rank Sector Weight
1 Financials 5.15%
2 Technology 3.69%
3 Energy 3.17%
4 Healthcare 2.1%
5 Communication Services 1.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCEC
1776
Capital Clean Energy Carriers
CCEC
$1.39B
$64K ﹤0.01%
2,731
+801
+42% +$18.8K
NAGE
1777
Niagen Bioscience
NAGE
$256M
$64K ﹤0.01%
10,819
-9,000
-45% -$48.6K
BTG icon
1778
B2Gold
BTG
$5.14B
$63K ﹤0.01%
20,480
+1,120
+6% +$3.02K
OCSL icon
1779
Oaktree Specialty Lending
OCSL
$1.03B
$63K ﹤0.01%
4,316
-1,403
-25% -$22.5K
ATYR
1780
aTyr Pharma
ATYR
$47.3M
$60K ﹤0.01%
1,214
FCSC
1781
DELISTED
Fibrocell Science Inc.
FCSC
$60K ﹤0.01%
18,618
+6,400
+52% +$55.9K
BRW
1782
Saba Capital Income & Opportunities Fund
BRW
$335M
$56K ﹤0.01%
5,537
-50
-0.9% -$512
CXE
1783
DELISTED
MFS High Income Municipal Trust
CXE
$56K ﹤0.01%
10,733
AEMD icon
1784
Aethlon Medical
AEMD
$1.55M
$55K ﹤0.01%
4
+2
+100% +$24.4K
INOD icon
1785
Innodata
INOD
$1.83B
$51K ﹤0.01%
37,325
TGB
1786
Trekor Metals
TGB
$2.56B
$51K ﹤0.01%
22,000
+100
+0.5% +$217
AST
1787
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$47K ﹤0.01%
+20,697
New +$52.4K
III icon
1788
Information Services Group
III
$185M
$46K ﹤0.01%
11,100
-1,000
-8% -$4.15K
NG icon
1789
NovaGold Resources
NG
$2.6B
$44K ﹤0.01%
11,150
-900
-7% -$3.58K
RAVE icon
1790
RAVE Restaurant Group
RAVE
$44.6M
$44K ﹤0.01%
30,080
RIGL icon
1791
Rigel Pharmaceuticals
RIGL
$680M
$43K ﹤0.01%
1,100
+100
+10% +$3.81K
PIR
1792
DELISTED
Pier 1 Imports, Inc.
PIR
$43K ﹤0.01%
525
+25
+5% +$2.22K
ASM
1793
Avino Silver & Gold Mines
ASM
$985M
$42K ﹤0.01%
31,000
-500
-2% -$679
INO icon
1794
Inovio Pharmaceuticals
INO
$80.6M
$42K ﹤0.01%
+841
New +$52.1K
TNDM icon
1795
Tandem Diabetes Care
TNDM
$1.17B
$42K ﹤0.01%
+18,000
New +$56.5K
NAVB
1796
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$42K ﹤0.01%
5,805
IMI
1797
DELISTED
Intermolecular, Inc.
IMI
$41K ﹤0.01%
30,000
-3,000
-9% -$3.61K
LEE icon
1798
Lee Enterprises
LEE
$167M
$40K ﹤0.01%
1,683
VNRX icon
1799
VolitionRx Ltd
VNRX
$12.2M
$39K ﹤0.01%
660
EYPT icon
1800
EyePoint Inc
EYPT
$1.02B
$38K ﹤0.01%
3,500

Similar funds

Creative Planning's Q4 2017 Portfolio in Review

As of Q4 2017, Creative Planning held 2,074 positions worth $23.2B, up 7.8% from $21.5B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Creative Planning deployed $913M of net new capital in Q4 2017, opening 189 new positions and adding to 821 existing holdings. Its largest new stake was Jagged Peak Energy Inc.: 333,976 shares worth $5.27M.

By sector, the portfolio is most concentrated in Financials at 5.1% of assets, up from 5.1% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was InterDigital, an estimated $97.8M trimmed.

  • Creative Planning's largest Q4 2017 buy was Jagged Peak Energy Inc.: 333,976 shares worth $5.27M.
  • Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2017, an estimated $208M increase.
  • Creative Planning's biggest Q4 2017 reduction was InterDigital, cutting an estimated $97.8M.
  • Creative Planning fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $4.24M.
  • Creative Planning's ten largest holdings make up 56% of its $23.2B portfolio in Q4 2017.
  • Creative Planning opened 189 new positions and closed 172 in Q4 2017.
  • Creative Planning's portfolio value rose 7.8% quarter-over-quarter to $23.2B.

Based on Creative Planning's 13F filing for Q4 2017, filed 17 Jan 2018.